Howard Birndorf

Howard Civian Birndorf (born February 21, 1950) is a biotechnology entrepreneur and one of the founders of the biotech industry in San Diego, California.[1]

Early life

Birnbaum was born in Detroit in 1950.[2] Birndorf received his B.A. in Biology from Oakland University, an M.S. in Biochemistry from Wayne State University,[3] and has received honorary Doctor of Science degrees from Oakland University and Wayne State University.

Career

Along with former University of California professor and current venture capitalist Ivor Royston, Birndorf founded San Diego's first biotech in 1978, the monoclonal antibody company Hybritech.[3] The company was subsequently bought by Eli Lilly and Company in 1986,[3] and Birndorf went on to found a number of other successful companies including Gen-Probe,[4] IDEC Pharmaceuticals (which merged with Biogen to form Biogen-Idec), and Ligand Pharmaceuticals.[5] Birndorf was also involved in the formation of Gensia (Sicor), and was a founding Director of Neurocrine Biosciences.[5][6] He was the founder and co-chair of the Coalition for 21st Century Medicine and was founder, Chairman and CEO of Nanogen, Inc.[6]

References
  1. "Forbes.com: Howard C. Birndorf". Forbes. Retrieved 2010-01-30.
  2. "Howard Birndorf Interview". UC San Diego. 2008. Retrieved 2019-12-03.
  3. Kramer, Mary (26 May 1997). "BIOTECH SUPERSTAR COULD PLANT HIS IDEAS HERE". Crain's Detroit Business. Retrieved 2020-09-22.
  4. Bigelow, Bruce (2011-11-16). "Xconomy: Nordhoff Retiring from Gen-Probe Board". Xconomy. Retrieved 2020-09-22.
  5. Fikes, Bradley (2018-05-09). "San Diego's Hybritech still influences local biotech, 40 years later". San Diego Union-Tribune. Retrieved 2020-09-22.
  6. Sterngold, James (1996-08-18). "The Johnny Appleseed of a Biotechnology Forest". The New York Times. ISSN 0362-4331. Retrieved 2020-09-22.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.